Attia, M.S.; Ewida, H.A.; Abdel Hafez, M.A.; El-Maraghy, S.A.; El-Sawalhi, M.M.
Altered Lnc-EGFR, SNHG1, and LincRNA-Cox2 Profiles in Patients with Relapsing-Remitting Multiple Sclerosis: Impact on Disease Activity and Progression. Diagnostics 2023, 13, 1448.
https://doi.org/10.3390/diagnostics13081448
AMA Style
Attia MS, Ewida HA, Abdel Hafez MA, El-Maraghy SA, El-Sawalhi MM.
Altered Lnc-EGFR, SNHG1, and LincRNA-Cox2 Profiles in Patients with Relapsing-Remitting Multiple Sclerosis: Impact on Disease Activity and Progression. Diagnostics. 2023; 13(8):1448.
https://doi.org/10.3390/diagnostics13081448
Chicago/Turabian Style
Attia, Mohamed S., Heba A. Ewida, Mohamed Aly Abdel Hafez, Shohda A. El-Maraghy, and Maha M. El-Sawalhi.
2023. "Altered Lnc-EGFR, SNHG1, and LincRNA-Cox2 Profiles in Patients with Relapsing-Remitting Multiple Sclerosis: Impact on Disease Activity and Progression" Diagnostics 13, no. 8: 1448.
https://doi.org/10.3390/diagnostics13081448
APA Style
Attia, M. S., Ewida, H. A., Abdel Hafez, M. A., El-Maraghy, S. A., & El-Sawalhi, M. M.
(2023). Altered Lnc-EGFR, SNHG1, and LincRNA-Cox2 Profiles in Patients with Relapsing-Remitting Multiple Sclerosis: Impact on Disease Activity and Progression. Diagnostics, 13(8), 1448.
https://doi.org/10.3390/diagnostics13081448
